The role of vitamin B6 in the prevention of haematological toxic effects of linezolid in patients with cancer

Journal of Antimicrobial Chemotherapy

Volumn 61, Issue 2, 2008, Pages 421-424

  Youssef, S ^a   Hachem, R ^a   Chemaly, R F ^a   Adachi, J ^a   Ying, J ^a   Rolston, K ^a   Raad, I ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Haematological toxicity; Leucopenia; Oxazolidinones; Thrombocytopenia

Indexed keywords

CREATININE; LINEZOLID; PYRIDOXINE; STEROID; ACETAMIDE DERIVATIVE; OXAZOLIDINONE DERIVATIVE;

ADULT; AGED; ANEMIA; ARTICLE; BACTERIAL INFECTION; BLOOD TOXICITY; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE DURATION; FEMALE; HUMAN; LEUKOPENIA; MALE; NEOPLASM; NEUTROPENIA; OPEN STUDY; THROMBOCYTOPENIA; COMPARATIVE STUDY; HEMATOLOGIC DISEASE; MIDDLE AGED; PHYSIOLOGY;

ACETAMIDES; ADULT; AGED; FEMALE; HEMATOLOGIC DISEASES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; OXAZOLIDINONES; VITAMIN B 6;

EID: 38349105024     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm506     Document Type: Article

References (10)

1. Wisplinghoff H, Bischoff T, Tallent SM et al. Nosocomial blood-stream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309-17.
2. Yanagihara K, Kaneko Y, Hirakata Y et al. Efficacy of linezolid against methicillin-resistant or vancomycin-insensitive Staphylococcus aureus in a model of hematogenous pulmonary infection. Antimicrob Agents Chemother 2002; 46: 3288-91.
3. Birmingham MC, Rayner CR, Meagher AK et al. Linezolid for the treatment of multidrug-resistant, Gram-positive infections: Experience from a compassionate-use program. Clin Infect Dis 2003; 36: 159-68.
4. Senneville E, Legout L, Valette M et al. Risk factors for anaemia in patients on prolonged linezolid therapy for chronic osteomyelitis: A case-control study. J Antimicrob Chemother 2004; 54: 798-802.
5. Bernstein W, Barile A. Mechanisms for linezolid-incluced anemia and thrombocytopenia. Ann Pharmacother 2003; 37: 517-20.
6. Spellberg B, Yoo T, Bayer A. Reversal of linezolid-associated cytopenias, but not peripheral neuropathy, by administration of vitamin B6. J Antimicrob Chemother 2004; 54: 832-5.
7. Plachouras D, Giannitsioti E, Athanassia S et al. No effect of pyridoxine on the incidence of myelosuppression during prolonged linezolid treatment. Clin Infect Dis 2006; 43: E89-91.
8. Harris JW, X-linked, pyridoxine-responsive sideroblastic anemia. N Engl J Med 1994; 330: 709-11.
9. Dawson MA, Davis A, Elliott P et al. Unezolid-induced dyserythropoiesis: Chloramphenicol toxicity revisited. Intern Med J 2005; 35: 626-8.
10. Wu VC, Wang YT, Wang CY et al. High frequency of linezolid-associated thrombocytopenia and anemia among patients with end-stage renal disease. Clin Infect Dis 2006; 42: 66-72.